• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Penumbra Inc.

COVID-19 upends medtech’s financial outlook

April 7, 2020 By Sean Whooley

The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]

Filed Under: Business/Financial News, Cardiovascular, Clinical Trials, Contract Manufacturing, Diabetes, Diagnostics, Featured, Genomics/Molecular Diagnostics, Health Technology, Imaging, Implants, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Check-Cap, coronavirus, COVID-19, Cutera Inc., Endologix, Hologic, Iradimed Corp, Livongo, Myomo Inc, Natus Medical Inc., NovoCure, Penumbra Inc., Shockwave Medical, Silk Road Medical Inc., Zynex

Penumbra appoints new chief financial and accounting officers

November 26, 2019 By Danielle Kirsh

Penumbra (NYSE:PEN) recently announced that it appointed Maggie Yuen as chief financial officer and Lambert Shiu as chief accounting officer, effective Dec. 2. Yuen replaces president and chief financial officer Sri Kosaraju. Kosaraju will continue to serve as president following the appointment. Prior to joining Penumbra, Yuen held a number of leadership roles in the manufacturing, […]

Filed Under: Featured, Implants, Neurological, Vascular Tagged With: Penumbra Inc.

Penumbra launches trial for Indigo blood clot aspiration device

October 10, 2019 By Sean Whooley

Penumbra (NYSE:PEN) said today that it enrolled the first patient into its Cheetah study of the Indigo aspiration device. The Alameda, Calif.-based company said the Cheetah trial is slated to enroll up to 400 patients with coronary thrombus who are referred for percutaneous coronary intervention. The study’s primary endpoint is a composition of cardiovascular death, recurrent […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Featured Tagged With: Penumbra Inc.

Dynatronics promotes COO Baker to replace von Jako as CEO | Personnel Moves, August 30, 2019

August 30, 2019 By Brad Perriello

After deciding this week that its CEO needs to be based in Eagan, Minn., and with chief executive Chris von Jako unwilling to relocate his family, Dynatronics (NSDQ:DYNT) promoted COO Brian Baker to the corner office, effective August 28. “After thoughtful consideration, the board of directors determined that the company’s CEO needs to be based in […]

Filed Under: Business/Financial News, Featured Tagged With: ATL Technology, Cook Medical, Dynatronics Corp, Echosens, Fresenius, Harmonic Bionics, Iradimed Corp, Orchestra BioMed, Penumbra Inc., Personnel Moves, UBS

Penumbra tops estimates with Q1 results, guides to high end of sales forecast

May 8, 2019 By Brad Perriello

Penumbra (NYSE:PEN) yesterday posted first-quarter results that topped the consensus forecast on Wall Street and guided toward the high end of its full-year sales outlook. The Alameda, Calif.-based neurovascular device maker reported profits of $10.7 million, or 30¢ per share, on sales of $128.4 million for the three months ended March 31, growing the bottom […]

Filed Under: Featured, MassDevice Earnings Roundup, Neurological, Vascular, Wall Street Beat Tagged With: Penumbra Inc.

Penumbra VR device wins FDA clearance

April 15, 2019 By Danielle Kirsh

Penumbra recently announced that it has received FDA 510(k) clearance for its Real Immersive virtual reality system. The Real Immersive System is an immersive virtual reality and display system that tracks upper extremity rehabilitation exercises for adults who have symptoms related to acute pain, cerebral palsy, stroke, orthopedic or neurodegenerative diseases. The exercise routines with the […]

Filed Under: 510(k), Regulatory/Compliance Tagged With: Penumbra Inc.

Penumbra revenue up but earnings down in Q4

February 27, 2019 By Chris Newmarker

Penumbra (NYSE:PEN) saw its revenue jump more than 25% year-over-year in the fourth quarter, but earnings were down for the Alameda, Calif.–based maker of devices to treat neuro and peripheral vascular conditions. Alameda, Calif.-based Penumbra’s stock is down about $15.57 per share, or 10.6%, to $131.25 as of midday trading. The company reported yesterday evening […]

Filed Under: Business/Financial News, Cardiovascular, Neurological, News Well, Wall Street Beat Tagged With: Penumbra Inc.

Penumbra acquires 90% interest in MVI Health JV, launches thrombectomy devices

September 4, 2018 By Fink Densford

Penumbra (NYSE:PEN) said today it acquired 40% of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90%, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology, Alameda, Calif.-based Penumbra said, though […]

Filed Under: Business/Financial News, Catheters, Vascular Tagged With: Penumbra Inc.

Penumbra shares rise on Q1 beat, growing sales

May 9, 2018 By Fink Densford

Shares in Penumbra (NYSE:PEN) rose today after the medical device maker topped expectations on Wall Street with its first quarter 2018 earnings results. The Alameda, Calif.-based company posted profits of $5.5 million, or 15¢ per share, on sales of $102.7 million for the three months ended March 31, seeing a swing from the red on the […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Penumbra Inc.

Penumbra shares rise on Q4, FY2017 earnings beat

February 28, 2018 By Fink Densford

Shares in Penumbra (NYSE:PEN) rose today after the medical device maker met expectations on Wall Street with its fourth quarter and fiscal year 2017 earnings results. The Alameda, Calif.-based company posted profits of $9.1 million, or 25¢ per share, on sales of $96 million for the 3 months ended December 31, seeing a massive swing from […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Penumbra Inc.

Penumbra touts non-inferiority in Compass aspiration thrombectomy trial

February 8, 2018 By Fink Densford

Penumbra (NYSE:PEN) late last month released results from the Compass trial of its aspiration thrombectomy system designed to treat acute ischemic stroke, touting that the system was shown to be non-inferior to stent retrievers. Results from the trial were presented at the International Stroke Conference, the Alameda, Calif.-based company said. Investigators in the trial aimed to […]

Filed Under: Blood Management, Clinical Trials, Vascular Tagged With: Penumbra Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS